GMNN and neoplasm: In total, 99 samples were tested; 10 samples did not pass the quality check due to the lack of tumor cells in the S/G2 phase of the cell cycle (<40 geminin-positive cells); 20 samples exhibited insufficient endogenous DNA damage (<25% of geminin-positive cells with γH2AX foci).